Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.

BACKGROUND AND OBJECTIVES: Prognostic factors reliably predicting outcomes for critically ill adolescent and young adult (AYA) patients undergoing allogeneic hematopoietic cell transplantation (allo-HSCT) are lacking. We assessed transplant and intensive care unit (ICU)-related factors impacting patient outcomes. PATIENTS AND METHODS: AYA patients who underwent allo-HSCT and required ICU admission at a Tertiary care Centre, during the period of 2003-2013, were included in this retrospective review. This was a non-interventional study. Only outcomes after the first allo-HSCT and index ICU admissions were analyzed. Disease-, transplant-, and ICU-related variables were analyzed to identify risk factors predictive of survival. RESULTS: Overall, 152 patients were included (males, 60.5%); median age at transplantation was 24 years (interquartile range [IQR] 18-32.5); median age at admission to the ICU was 25.8 years (IQR 19-34). Eighty-four percent underwent transplantation for a hematological malignancy; 129 (85%) received myeloablative conditioning. Seventy-one percent of ICU admissions occurred within the first year after allo-HSCT. ICU admission was primarily due to respiratory failure (47.3%) and sepsis (43.4%). One hundred and three patients (68%) died within 28 days of ICU admission. The 1- and 5-year overall survival rates were 19% and 17%, respectively. Main causes for ICU-related death were refractory septic shock with multiorgan failure (n = 49, 32%) and acute respiratory distress syndrome (ARDS) (n = 39, 26%). Univariate analysis showed that ICU mortality was associated with an Acute Physiology and Chronic Health Evaluation (APACHE) II score >20, a sequential organ failure assessment (SOFA score) > 12, a high lactate level, anemia, thrombocytopenia, leukopenia, hyperbilirubinemia, a high international normalized ratio (INR) and acute graft-versus-host disease (GVHD). Multivariate analysis identified thrombocytopenia, high INR, and acute GVHD as independent predictors of mortality. CONCLUSIONS: In AYA allo-HSCT patients admitted to the ICU, mortality remains high. Higher SOFA and APACHE scores, the need for organ support, thrombocytopenia, coagulopathy, and acute GVHD predict poor outcomes.

The Predictive Ability of PV-ACO2 Gap and PV-ACO2/CA-VO2 Ratio in Shock: A Prospective, Cohort Study.

INTRODUCTION: Compromised tissue oxygenation leads to anaerobiosis, leading to organ failure and death. This study attempts to demonstrate the predictive abilities of the Pv-aCO2 gap and Pv-aCO2/Ca-vO2 ratio in shock patients undergoing resuscitation. METHODS: In a prospective study, consecutive patients with shock were included. Timed measurements of Pv-aCO2 gap, ScvO2, lactate, and Pv-aCO2/ Ca-vO2 ratio were obtained. The association between the mortality and each variable at all intervals was analyzed. Receiver operating characteristics curves were built. RESULTS: Fifty patients were enrolled. Intensive care unit survivors had a higher Pv-aCO2/ Ca-vO2 ratio at time 0 (0.21, interquartile range [IQR] 0.14 vs. 0.27, IQR 0.38, P = 0.032) and at 3 h (0.27, IQR 0.08 vs. 0.21, IQR 0.12, P = 0.035).Twenty-eight day survival was higher in patients with a low Pv-aCO2 gap at time 0 (7.5, IQR 7 vs. 4.8, IQR 5, P = 0.007).Baseline Pv-aCO2 gap and Pv-aCO2/Ca-vO2 ratio showed good ability to predict 28-day mortality as seen by AUC 0.728 (95% CI 0.578-0.877, P = 0.007) and 0.711 (95% CI 0.563-0.860, P = 0.013). A cut-off point of Pv-aCO2 gap ≥6 mm Hg identified 28-day mortality (75% vs. 45.5%, P = 0.034). The best cutoff values, at baseline, to predict 28-day mortality were 0.25 for the Pv-aCO2/Ca-vO2 ratio (sensitivity 58%, specificity 85%, LR+ 3.86, LR- 0.49) and 6.3 for the Pv-aCO2 gap (sensitivity 58%, specificity 79%, LR+ 2.76, LR- 0.53). CONCLUSION: This study suggests that Pv-aCO2 gap and Pv-aCO2/Ca-vO2 ratio are discriminating predictors of 28-day mortality and can be used to provide supplementary information during resuscitation in shock.